Galectin Therapeutics GALT
NASDAQ GALT
$3.76 -0.12 (-3.09%)
At close: Oct 1, 2026 · 4:00 PM EDT

Galectin Therapeutics (GALT) Accumulated Depreciation (2011 - 2024)

Updated

Galectin Therapeutics' Accumulated Depreciation was $74,000 in Q4 2024, unchanged from $74,000 a year earlier.

Analysis

Galectin Therapeutics (GALT) Accumulated Depreciation (2011 - 2024) Analysis & Trends

From Q4 2011 onward, Galectin Therapeutics has reported Accumulated Depreciation for 12 quarters.

  • Accumulated Depreciation shows a four-year compound annual growth rate of 0.0% (FY2020 to FY2024).
  • In earlier years, Accumulated Depreciation was $74,000 in FY2023 (unchanged), $74,000 in FY2022 (unchanged), $74,000 in FY2021 (unchanged) and $74,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Galectin Therapeutics 257.29 Mn 257.29 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 74,000.00
Dec 31, 2023 74,000.00
Dec 31, 2022 74,000.00
Dec 31, 2021 74,000.00
Dec 31, 2020 74,000.00
Dec 31, 2017 74,000.00
Dec 31, 2016 74,000.00
Dec 31, 2015 74,000.00
Dec 31, 2014 73,000.00
Dec 31, 2013 71,000.00
Dec 31, 2012 66,000.00
Dec 31, 2011 315,000.00
API Access

Galectin Therapeutics Accumulated Depreciation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=GALT&period=max&api_key=YOUR_API_KEY